Impax Inks $145M Deal With Direct Purchasers In Opana MDL
Norman, Okla. — Opening statements were made Tuesday in a landmark trial that could determine whether states can hold drug makers responsible for the opioid crisis. Thousands of families will be watching closely, as the case could affect other pending lawsuits.
FDA declines to approve Mallinckrodt`s abuse-deterrent opioid painkiller
US Food and Drug Administration (FDA) Commissioner Scott Gottlieb on Wednesday announced that the agency intends to withdraw its 2014 draft guidance on developing drugs and biologics to treat pain and replace it with at least four new guidance documents over the coming year.
(Reuters) - The U.S. Food and Drug Administration declined to approve Pain Therapeutics Inc’s abuse-deterrent opioid treatment Remoxy for the fourth time, sending the company’s shares down 35 percent to a record low.
Mallinckrodt subpoenaed, again, over sales of oxymorphone in growing opioid crisis
Ascent Pharm’s Generics Oxymorphone Hydrochloride Receives Approval In US
Pharmaceutical company Endo International Plc said on Thursday it had received a grand jury subpoena from federal prosecutors in Miami seeking documents related to drugs it produces that contain the opioid painkiller oxymorphone.
Takeda has closed the book on its inflammatory bowel disease awareness campaign in the form of a graphic novel. In the end, the Unbeatables superhero team prevailed—not only over the evil trillionaire trying to take over the world, but also over IBD.
GlaxoSmithKline CEO Emma Walmsley outlined her fix for the company's long-standing pipeline woes. The plan is to give the commercial team a bigger say in pipeline decisions. Article